Amundi Increases Stake in HealthEquity, Inc. $HQY

Key Points

• Amundi increased its HealthEquity stake by 33.6% in the second quarter, acquiring 22,735 additional shares and bringing its holdings to 90,327 shares valued at approximately $8.16 million.
• HealthEquity reported quarterly EPS of $1.24, exceeding the $1.19 consensus estimate, while revenue rose 95.5% year over year to $350.73 million.
• Analysts maintain a “Moderate Buy” consensus rating with an average price target of $111.87, although insiders have sold 12,456 shares worth roughly $1.26 million over the past 90 days.

Amundi increased its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 33.6% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 90,327 shares of the company's stock after acquiring an additional 22,735 shares during the period. Amundi owned approximately 0.11% of HealthEquity worth $8,158,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Fifth Third Wealth Advisors LLC grew its stake in shares of HealthEquity by 4.2% during the 1st quarter. Fifth Third Wealth Advisors LLC now owns 2,872 shares of the company's stock valued at $240,000 after buying an additional 116 shares during the period. Truist Financial Corp boosted its holdings in HealthEquity by 4.9% in the fourth quarter. Truist Financial Corp now owns 2,537 shares of the company's stock valued at $232,000 after acquiring an additional 119 shares during the last quarter. Fiduciary Trust Co grew its position in HealthEquity by 3.4% during the third quarter. Fiduciary Trust Co now owns 3,669 shares of the company's stock valued at $348,000 after acquiring an additional 120 shares during the period. Larson Financial Group LLC grew its position in HealthEquity by 24.4% during the third quarter. Larson Financial Group LLC now owns 628 shares of the company's stock valued at $60,000 after acquiring an additional 123 shares during the period. Finally, Merit Financial Group LLC grew its position in HealthEquity by 8.9% during the third quarter. Merit Financial Group LLC now owns 2,112 shares of the company's stock valued at $200,000 after acquiring an additional 172 shares during the period. 99.55% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have recently commented on HQY. Citigroup restated a "market outperform" rating on shares of HealthEquity in a report on Friday, August 28th. Wall Street Zen cut HealthEquity from a "buy" rating to a "hold" rating in a report on Saturday, September 5th. Raymond James Financial reissued a "strong-buy" rating on shares of HealthEquity in a research report on Thursday, September 3rd. Citizens Jmp raised their price target on shares of HealthEquity from $110.00 to $111.00 and gave the company a "market outperform" rating in a report on Monday, June 1st. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of HealthEquity from $135.00 to $142.00 and gave the company a "buy" rating in a research report on Monday, August 31st. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $111.87.

Insider Transactions at HealthEquity

In related news, EVP Michael Fiore sold 2,354 shares of HealthEquity stock in a transaction on Friday, July 10th. The shares were sold at an average price of $95.00, for a total value of $223,630.00. Following the completion of the sale, the executive vice president owned 52,244 shares in the company, valued at approximately $4,963,180. The trade was a 4.31% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Adrian T. Dillon sold 7,632 shares of the company's stock in a transaction on Tuesday, August 25th. The shares were sold at an average price of $104.61, for a total transaction of $798,383.52. Following the completion of the sale, the director directly owned 62,395 shares in the company, valued at $6,527,140.95. This represents a 10.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 12,456 shares of company stock worth $1,256,664. Corporate insiders own 1.60% of the company's stock.

HealthEquity Stock Up 1.8%

Shares of NASDAQ:HQY opened at $96.26 on Friday. The company has a quick ratio of 2.99, a current ratio of 2.99 and a debt-to-equity ratio of 0.47. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $107.62. The company has a 50 day moving average of $99.60 and a two-hundred day moving average of $89.23. The company has a market capitalization of $7.96 billion, a price-to-earnings ratio of 34.75, a price-to-earnings-growth ratio of 1.52 and a beta of 0.22.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its earnings results on Thursday, August 27th. The company reported $1.24 EPS for the quarter, topping analysts' consensus estimates of $1.19 by $0.05. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The business had revenue of $350.73 million for the quarter, compared to analysts' expectations of $349.22 million. HealthEquity's revenue was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. As a group, analysts forecast that HealthEquity, Inc. will post 3.93 earnings per share for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services for consumer-directed benefits and healthcare savings accounts. The company helps employers, benefits advisors and individuals manage tax-advantaged accounts, including health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), commuter benefits and other employee benefit programs.

Its offerings include account administration, payment cards, reimbursement services, benefits communication, compliance support, healthcare spending tools and investment options for eligible HSA funds.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.